A Retrospective Cohort Study on Patients with Hidradenitis Suppurativa

Dermatology : International Journal for Clinical and Investigative Dermatology
S Morteza Seyed JafariRobert E Hunger

Abstract

Hidradenitis suppurativa (HS) is one of the most distressing conditions observed in dermatology and has a substantial negative effect on the quality of life of affected persons. The aim of this study was to evaluate different treatment strategies in patients with HS. In a retrospective cohort, all patients with HS (July 2015 to March 2017) were reviewed. Collected data consisted of patients' demographics, clinical characteristics, psychosocial situation, and previous and current treatments. In addition, therapy response to the most recent prescribed treatments was assessed. 102 patients (38 females, 64 males; median age 37.5 years) were included in this study. 68.4% of patients had BMI ≥25, and 76.5% of patients were current smokers. Hurley stages I, II, and III were detected in 13.5, 53.1, and 33.3% of patients, respectively. The most commonly administered treatments were surgery (67.6%), nonantibiotic topical therapies (72.5%), antibiotic topical therapies (55.9%), systemic antibiotics (88.2%), and biologics in 11.8% of the patients. 84.6% of the patients showed a response (27.5 and 47.1% partial and complete response, respectively) to the treatments. HS as a chronic, recurrent inflammatory skin disease is associated with smo...Continue Reading

References

Aug 1, 1968·Archives of Dermatology·F TennantJ F Mullins
Nov 1, 1996·Clinical and Experimental Dermatology·G B JemecN H Nielsen
Apr 18, 2001·Journal of the European Academy of Dermatology and Venereology : JEADV·J M von der Werth, H C Williams
Oct 27, 2001·Clinical and Experimental Dermatology·R A Palmer, M Keefe
Nov 14, 2006·Journal of the American Academy of Dermatology·Pierre WolkensteinUNKNOWN Quality of Life Group of the French Society of Dermatology
Dec 21, 2007·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Daniela MeixnerWolfram Sterry
Aug 5, 2008·Journal of the American Academy of Dermatology·Jean E RevuzSylvie Bastuji-Garin
Mar 19, 2009·Journal of the American Academy of Dermatology·Ali AlikhanDaniel B Eisen
May 15, 2009·The British Journal of Dermatology·K SartoriusJ Lapins
Aug 8, 2009·Experimental Dermatology·Maximilian von LaffertWolfgang Christian Marsch
Aug 18, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·J Revuz
Jun 9, 2010·Acta Dermato-venereologica·Lukasz MatusiakJacek C Szepietowski
Mar 12, 2011·Acta Dermato-venereologica·Solveig Esmann, Gregor B E Jemec
Jan 13, 2012·The New England Journal of Medicine·Gregor B E Jemec
Nov 28, 2012·Surgery Today·Erhan AysanMahmut Muslumanoglu
Sep 5, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·I E DeckersE P Prens
Sep 5, 2014·Seminars in Cutaneous Medicine and Surgery·Robert G Micheletti
Feb 3, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·C C ZouboulisG B E Jemec
Jul 23, 2015·The British Journal of Dermatology·D M SaunteG B E Jemec
Oct 17, 2015·Journal of the American Academy of Dermatology·Gregor B E Jemec, Alexa B Kimball
Jul 28, 2016·Journal of the American Academy of Dermatology·Inge E DeckersErrol P Prens
Aug 3, 2016·The British Journal of Dermatology·P Theut RiisG B E Jemec
Oct 4, 2016·Journal of the American Academy of Dermatology·Peter Theut RiisGregor B E Jemec
Apr 6, 2017·Journal of the American Academy of Dermatology·Christian PoschKlemens Rappersberger
May 20, 2017·Journal of the American Academy of Dermatology·Patrizia WeberRobert E Hunger
Aug 11, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·E DaudenJ García-Campayo
Aug 31, 2017·JAMA Dermatology·Carine HourietRobert E Hunger
Jan 23, 2018·The Australasian Journal of Dermatology·Dunja Ana VekicGeoffrey David Cains

❮ Previous
Next ❯

Citations

Oct 28, 2019·International Journal of Dermatology·Franchesca ChoiNatasha A Mesinkovska
Nov 9, 2019·Journal of Cutaneous Medicine and Surgery·Mavişe Yüksel, Pelin Basım
Mar 3, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·A V MarzanoF Rongioletti
Mar 21, 2020·Frontiers in Medicine·S Morteza Seyed JafariChristoph Schlapbach
Jan 15, 2020·Dermatology : International Journal for Clinical and Investigative Dermatology·Gregory C PetersonSo Yeon Paek
Jan 28, 2021·Dermatology : International Journal for Clinical and Investigative Dermatology·Morgane CondaminaEmilie Sbidian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of Cutaneous Medicine and Surgery
Marcus G TanRaed Alhusayen
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]
Lixia Z Ellis
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]
Xu HaoxiangWu Xinfeng
© 2022 Meta ULC. All rights reserved